Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2017 | Pharmacokinetics: an important factor in cancer treatment

The pharmacokinetics involved with different drugs greatly influences how they are used in the treatment of cancer patients. Diana Lüftner, from the Humboldt University, Berlin, Germany talks to us about when it is acceptable for clinicians to alter their patient’s medication. Prof. Lüftner stresses the importance of differentiating between drug types to ensure patients receive optimal treatment, using the drug trastuzumab as an example. This interview was recorded at the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.